Edwards Expects Up To $190 Million In Transcatheter Valve Sales In 2010
This article was originally published in The Gray Sheet
Executive Summary
Edwards LifeSciences estimates sales of its Sapien transcatheter aortic heart valve will be in the range of $170 million to $190 million in 2010, the company said during its Dec. 10 investor day at its Irvine, Calif., headquarters